These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7783285)

  • 1. Acellular pertussis vaccine scores high in trial.
    Marwick C
    JAMA; 1995 Jun; 273(24):1892-3. PubMed ID: 7783285
    [No Abstract]   [Full Text] [Related]  

  • 2. Acellular pertussis vaccine hailed for infants.
    Marwick C
    JAMA; 1995 Aug; 274(6):446-7. PubMed ID: 7629938
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial.
    Blennow M; Granström M; Jäätmaa E; Olin P
    Pediatrics; 1988 Sep; 82(3):293-9. PubMed ID: 3043367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular pertussis vaccines: what lies ahead?
    Wiedermann BL
    Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):676-7. PubMed ID: 8778580
    [No Abstract]   [Full Text] [Related]  

  • 6. Acellular pertussis vaccine is licensed for infants.
    Marwick C
    JAMA; 1996 Aug; 276(7):516-8. PubMed ID: 8709389
    [No Abstract]   [Full Text] [Related]  

  • 7. Acellular pertussis vaccine 63% to 92% effective.
    J Fam Pract; 2006 Jan; 55(1):12. PubMed ID: 16453953
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
    Kato T; Kaku H; Arimoto Y
    Tokai J Exp Clin Med; 1988; 13 Suppl():35-8. PubMed ID: 3078808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6.
    Blennow M; Granström M; Olin P; Tiru M; Jäätmaa E; Askelöf P; Sato Y
    Dev Biol Stand; 1986; 65():185-90. PubMed ID: 3549397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition of acellular pertussis and combination vaccines: a general review.
    Jadhav SS; Gairola S
    Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
    Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive bacterial infections during an efficacy trial of acellular pertussis vaccines--implications for future surveillance in pertussis vaccine programmes.
    Olin P; Romanus V; Storsaeter J
    Tokai J Exp Clin Med; 1988; 13 Suppl():143-4. PubMed ID: 3078803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
    Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
    J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.
    Kuno-Sakai H; Kimura M
    Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acellular pertussis vaccine (Pa)].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):325-9. PubMed ID: 7491431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of acellular pertussis vaccines].
    Wirsing von König CH; Finger H
    Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an acellular pertussis vaccine among adolescents and adults.
    Ward JI; Cherry JD; Chang SJ; Partridge S; Lee H; Treanor J; Greenberg DP; Keitel W; Barenkamp S; Bernstein DI; Edelman R; Edwards K;
    N Engl J Med; 2005 Oct; 353(15):1555-63. PubMed ID: 16221778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approval of a fourth acellular pertussis vaccine for use among infants and young children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(43):934-6. PubMed ID: 9822368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.